Evidentli Expands Advisory Board
Evidentli is delighted to announce the expansion of our scientific and strategic advisory board, to further extend our ability to help our health and life sciences clients realise value at scale.
“Our advisory board helped our clients establish healthier, harmonised data assets efficiently, effectively at scale,accelerating their ability to generate and disseminate evidence and collaborate with their colleagues on evidence generation.” said Guy Tsafnat, Evidentli’s Founder,
Evidentli was already privileged in having been able, over the past 3 years, to draw on the invaluable counsel of leaders and pioneers in the field of evidence-based medicine, health information standards, and AI in healthcare, with a long-standing scientific and strategic advisory board, chaired by Prof. Enrico Coeira that includes Dr Blackford Middleton, Davera Gabriel, Grahame Grieve, Prof. Ken Mandl and Prof. Paul Glasziou.
We are delighted to welcome five exceptional new members to this distinguished advisory board, who bring a wealth of entrepreneurial experience in designing innovative uses of data into driving value at scale for health systems and life sciences stakeholders, worldwide: Prof. Rachel Dunscombe, Dr Abel Kho, Matt Lowe, Milind Kamkolcar and Marcus Vass.
“We are exceptionally thrilled to have new members of such caliber express confidence in growth and our ability to deliver solutions that delight our clients.” said David Champeaux, Evidentli’s CEO.
Rachel Dunscombe is currently CEO of OpenEHR International. Until August 2022 Rachel spent over five years as the CEO of the NHS Digital Academy. She has provided advisory services to the UK Secretary of State for Health, been a member of the UK AI council and through her academic work Rachel has received a Visiting Professorship at Imperial College, London. Rachel is formerly the Director of Digital/CIO for Salford/NCA Group which under her leadership was the NHS’s most digitally mature organisation 2017.
Dr. Abel Kho is an Internist and Professor of Medicine and Preventive Medicine in the Northwestern University Feinberg School of Medicine and Founding Director of the Institute for Artificial Intelligence in Medicine (2020). His research focuses on developing novel methods to integrate and analyze diverse data (e.g. electronic health records, administrative data, geospatial data) and the real-world application of privacy enhancing technologies. He is an elected Fellow of the American College of Medical Informatics and recipient of the Donald A.B. Lindbergh Award for Innovation in Informatics.
Matt Lowe is the Founder and CEO of performance.io and a pharmaceutical digital transformation leader with over 23 years of experience. He began client-side before leading digital operations at a network agency, and his performance.io team has since helped companies like AstraZeneca, Sanofi, Novo Nordisk, Novartis, Galderma, GSK, and ViiV revolutionize their online engagement model. A visionary in digital innovation, Matt combines deep industry knowledge with expertise in AI and emerging technologies – optimizing visibility across both traditional and AI-driven search – to drive meaningful engagement with HCPs and patients. He is an investor in a number of Health and Tech companies and sits on the Board of the Peace Love Foundation Mental Health charity (pro bono).
Milind Kamkolkar is a globally recognized healthcare & life sciences technology executive and venture leader with over two decades of experience building and scaling companies and market-leading capabilities at the intersection of life sciences, healthcare, and deep tech. He has co-founded and incubated multiple breakthrough startups—including ventures at Flagship Pioneering, RA Capital, Arch, and General Catalyst—raising nearly $500M in funding. As the first Chief Data Officer in global pharma (Sanofi) and a senior executive at Novartis, Milind pioneered enterprise AI transformations and forged strategic alliances with Apple, AWS, Microsoft, and Google. He advises boards, CEOs, and VCs across biotech, AI, and venture capital, and has been invited to speak at forums including TEDx, Stanford, Harvard, and the World Economic Forum.
Marcus Vass is a senior Technology and IP lawyer based in London. He is head of Digital Health at international law firm Osborne Clarke LLP and has also worked for 15 years in Beijing and Hong Kong. He is a guest lecturer on the MSc in Translational Health at the University of Oxford and has also taught at Said Business School, Chairman of an AI spin out from Oxford University Innovation and appointed as a board Advisor to companies in Europe and APAC.